The HPC is changing
We will soon be switching to a new High Performance Cluster, called Double Helix. This will mean that some of the commands you use to connect to the HPC and call modules will change. We will inform you by email when you are switching over, allowing you to make the necessary changes to your scripts. Please check our HPC changeover notes for more details on what will change.
LSF project codesΒΆ
To run any jobs on the HPC, you will need to use your project code.
You can see what queues are assigned to you using:
bugroup -w | grep <your_username> | awk '{print $1}'
These are the current LSF queues and project codes. Updated on 8th November 2023.
| GECIP domain or Discovery Forum | Project code |
|---|---|
| Breast cancer | re_gecip_cancer_breast |
| Childhood cancer | re_gecip_cancer_childhood |
| Colorectal cancer | re_gecip_cancer_colorectal |
| Glioma | re_gecip_cancer_glioma |
| Haematological malignancy | re_gecip_cancer_haem |
| Head and Neck Cancer | re_gecip_cancer_head_neck |
| Lung cancer | re_gecip_cancer_lung |
| Melanoma | re_gecip_cancer_melanoma |
| Neuroendocrine cancer | re_gecip_cancer_neuroendocrine |
| Ovarian cancer | re_gecip_cancer_ovarian |
| Pan-cancer | re_gecip_cancer_pan |
| Prostate cancer | re_gecip_cancer_prostate |
| Renal cell carcinoma | re_gecip_cancer_renal_cell |
| Sarcoma | re_gecip_cancer_sarcoma |
| Testicular cancer | re_gecip_cancer_testicular |
| Cancer of unknown primary | re_gecip_cancer_unknown_primary |
| Uppergastrointestinal cancer | re_gecip_cancer_upper_gi |
| Cardiovascular | re_gecip_cardiovascular |
| Endocrine and metabolism | re_gecip_endocrine_and_metabolism |
| Enhanced Interpretation | re_gecip_enhanced_interpretation |
| Ethics and social science | re_gecip_ethics_social_science |
| Functional crosscutting | re_gecip_functional_crosscutting |
| Functional effects | re_gecip_functional_effects |
| Non-malignant haematological and haemostasis disorders | re_gecip_haem_disorders |
| Health Economics | re_gecip_health_economics |
| Electronic health records | re_gecip_health_records |
| Hearing and sight | re_gecip_hearing_and_sight |
| Immune disorders | re_gecip_immune |
| Inherited cancer predisposition | re_gecip_inherited_cancer_predisposition |
| Quantitative methods, machine learning and functional genomics | re_gecip_machine_learning |
| Musculoskeletal | re_gecip_musculoskeletal |
| Neurology | re_gecip_neurology |
| Paediatrics | re_gecip_paediatrics |
| Population genomics | re_gecip_population_genomics |
| Renal | re_gecip_renal |
| Respiratory | re_gecip_respiratory |
| Skin | re_gecip_skin |
| Stratified medicine | re_gecip_stratified_medicine |
| Abbvie | re_df_abbvie_1 |
| Alexion | re_df_alexion |
| Alnylam | re_df_alnylam |
| Astellas | re_df_astellas |
| Astrazeneca | re_df_astrazeneca |
| Bayer | re_df_bayer |
| Berg_health | re_df_berg_health |
| Biogen | re_df_biogen |
| Biomarin | re_df_biomarin |
| Bioxplor | re_df_bioxplor |
| Bristol-Myers Squibb | re_df_bms |
| Cellworks | re_df_cellworks |
| Commercial | re_df_commercial |
| Congenica | re_df_congenica |
| Daiichi | re_df_daiichi |
| Dnastack | re_df_dnastack |
| Genomics_plc | re_df_genomics_plc |
| Gsk | re_df_gsk |
| Helomics | re_df_helomics |
| Hummingbird_bio | re_df_hummingbird_bio |
| Illumina | re_df_illumina |
| Integral | re_df_integral |
| Ionis | re_df_ionis |
| Iqvia | re_df_iqvia |
| Lifebit | re_df_lifebit |
| Macusoft | re_df_macusoft |
| Merck | re_df_merck |
| Msd | re_df_msd |
| Myneo | re_df_myneo |
| My personal therapeutics | re_df_my_personal_therapeutics |
| Novartis | re_df_novartis |
| ONT (Oxford Nanopore Technologies) | re_df_ONT |
| Pangea | re_df_pangea |
| Qiagen | re_df_qiagen |
| Rhythm | re_df_rhythm |
| Roche | re_df_roche |
| Roche Collaboration | re_df_roche_dw_collaboration |
| Serinusbio | re_df_serinusbio |
| Servier | re_df_servier |
| Silence_therapeutics | re_df_silence_therapeutics |
| Sysmex | re_df_sysmex |
| Takeda | re_df_takeda |
| The Hyve | re_df_the_hyve |
| UCB | re_df_ucb |